GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,507,000 | +465.8% | 30,000 | +200.0% | 0.08% | +78.3% |
| Q3 2019 | $1,150,000 | -33.3% | 10,000 | 0.0% | 0.05% | +12.2% |
| Q2 2019 | $1,724,000 | +2.3% | 10,000 | 0.0% | 0.04% | -21.2% |
| Q1 2019 | $1,686,000 | +15.4% | 10,000 | -33.3% | 0.05% | -10.3% |
| Q4 2018 | $1,461,000 | -57.7% | 15,000 | -25.0% | 0.06% | -21.6% |
| Q3 2018 | $3,455,000 | +23.8% | 20,000 | 0.0% | 0.07% | +8.8% |
| Q2 2018 | $2,791,000 | +147.6% | 20,000 | +100.0% | 0.07% | +195.7% |
| Q1 2018 | $1,127,000 | -57.3% | 10,000 | -50.0% | 0.02% | -52.1% |
| Q4 2017 | $2,640,000 | +160.1% | 20,000 | +100.0% | 0.05% | +140.0% |
| Q3 2017 | $1,015,000 | +1.2% | 10,000 | 0.0% | 0.02% | -35.5% |
| Q2 2017 | $1,003,000 | -17.0% | 10,000 | 0.0% | 0.03% | -6.1% |
| Q1 2017 | $1,209,000 | +8.1% | 10,000 | 0.0% | 0.03% | -8.3% |
| Q4 2016 | $1,118,000 | -60.2% | 10,000 | -75.3% | 0.04% | -58.6% |
| Q4 2015 | $2,812,000 | +23.4% | 40,500 | +62.0% | 0.09% | +74.0% |
| Q1 2015 | $2,278,000 | +108.8% | 25,000 | +85.2% | 0.05% | +100.0% |
| Q3 2014 | $1,091,000 | -77.4% | 13,500 | -70.0% | 0.02% | -78.4% |
| Q2 2014 | $4,828,000 | +137.8% | 45,000 | +31.6% | 0.12% | +182.9% |
| Q1 2014 | $2,030,000 | – | 34,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|